Viral bioterrorism: Learning the lesson of Ebola virus in West Africa 2013-2015

Virus Research

Volumn 210, Issue , 2015, Pages 318-326

  Cenciarelli, Orlando ^a   Gabbarini, Valentina ^a   Pietropaoli, Stefano ^b   Malizia, Andrea ^a   Tamburrini, Annalaura ^a   Ludovici, Gian Marco ^a   Carestia, Mariachiara ^a   Di Giovanni, Daniele ^a   Sassolini, Alessandro ^a   Palombi, Leonardo ^a   Bellecci, Carlo ^a   Gaudio, Pasquale ^a  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

^b ROMA TRE UNIVERSITY   (Italy)

Author keywords

Bioterrorism; BWA; Ebola virus; Hemorrhagic fever; West Africa

Indexed keywords

AFRICA; AIRPORT; BIOLOGICAL WARFARE; BIOLOGICAL WARFARE AGENT; EBOLA HEMORRHAGIC FEVER; EBOLAVIRUS; EPIDEMIC; FATALITY; HUMAN; HYPOTHESIS; NONHUMAN; PRIORITY JOURNAL; RAILWAY; REVIEW; SHIP; URBAN AREA; VIRUS TRANSMISSION; BIOTERRORISM; HEMORRHAGIC FEVER, EBOLA; PATHOGENICITY; VIROLOGY;

BIOLOGICAL WARFARE AGENT;

AFRICA, WESTERN; BIOLOGICAL WARFARE AGENTS; BIOTERRORISM; EBOLAVIRUS; HEMORRHAGIC FEVER, EBOLA; HUMANS;

EID: 84947789190     PISSN: 01681702     EISSN: 18727492     Source Type: Journal    
DOI: 10.1016/j.virusres.2015.09.002     Document Type: Review

References (73)

1. Baize S., Pannetier D., Oestereich L., Rieger T., Koivogui L., Magassouba N., Soropogui B., Sow M.S., Keïta S., et al. Emergence of Zaire Ebola virus disease in Guinea. N. Engl. J. Med. 2014, 371(15):1418-1425.
2. Berger S.A., Shapira I. Hemorrhagic fevers and bioterror. IMAJ 2002, 4:513-519.
3. Bray M. Defense against filoviruses used as biological weapons. Antivir. Res. 2003, 57(1):53-60.
4. Bray M. Viral bioterrorism and antiviral countermeasures. Antiviral Drug Discovery for Emerging Diseases and Bioterrorism Threats 2005, John Wiley & Sons, Inc., Hoboken, NJ, USA. P.F. Torrence (Ed.).
5. Bray M. Viral bioterrorism and antiviral countermeasures. Antiviral Drug Discovery for Emerging Diseases and Bioterrorism Threats 2005, John Wiley & Sons, NJ, USA. P.F. Torrence (Ed.).
6. Bukreyev A.A., Chandran K., Dolnik O., Dye J.M., Ebihara H., Leroy E.M., Mühlberger E., Netesov S.V., Patterson J.L., et al. Discussions and decisions of the 2012-2014 international committee on taxonomy of viruses (ICTV) filoviridae study group, January 2012-June 2013. Arch. Virol. 2014, 159(4):821-830.
7. Carestia M., Pizzoferrato R., Cenciarelli O., D'Amico F., Malizia A., Gelfusa M., Scarpellini D., Gaudio P. Fluorescence measurements for the identification of biological agents features for the construction of a spectra database. In Photonics Technologies, 2014 Fotonica AEIT Italian Conference on 2014, (pp . 1-4). IEEE.
8. Carus S.W. The poor man's atomic bomb?. Biological Weapons in the Middle East 1991, The Washington Institute for Near East Policy. Policy Papers Number 23., Washington DC, USA.
9. Cenciarelli O., Rea S., Carestia M., D'Amico F., Malizia A., Bellecci C., Gaudio P., Gucciardino A., Fiorito R. Bioweapons and bioterrorism: a review of history and biological agents. Defence S&T Tech. Bull. 2013, 6:111-129.
10. Cenciarelli O., Pietropaoli S., Gabbarini V., Carestia M., D'Amico F. Use of non-pathogenic biological agents as biological warfare simulants for the development of a stand-off detection system. J. Microb. Biochem. Technol. 2014, 6:375-380.
11. Cenciarelli O., Pietropaoli S., Frusteri L., Malizia A., Carestia M., D'Amico F., Sassolini A., Di Giovanni D., Tamburrini A., Palombi L., Bellecci C., Gaudio P. Biological emergency management: the case of ebola 2014 and the air transportation involvement. J. Microb. Biochem. Technol. 2014, 6(5). 274-253.
12. Centers for Disease Control and Prevention (CDC) Recognition of illness associated with the intentional release of a biologic agent. MMWR Morb. Mortal. Wkly. Rep. 2001, 50(41):893.
13. Centers for Disease Control and Prevention (CDC). Emergency Preparedness and Response. Bioterrorism Overview. http://emergency.cdc.gov/bioterrorism/overview.asp.
14. Centers for Disease Control and Prevention (CDC). Viral Haemorrhagic Fevers (VHFs). http://www.cdc.gov/vhf/virus-families/filoviridae.html.
15. Centers for Disease Control and Prevention (CDC). Travelers' Health -Chapter 3: Infectious disease related to travel. http://wwwnc.cdc.gov/travel/yellowbook/2014/chapter-3-infectious-diseases-related-to-travel/viral-hemorrhagic-fevers.
16. Centers for Disease Control and Prevention (CDC). EBOLA (Ebola virus disease). http://www.cdc.gov/vhf/ebola/.
17. Centers for Disease Control and Prevention (CDC). Emergency Preparedness and Response: Bioterrorism Agents/Disease. http://www.bt.cdc.gov/agent/agentlist-category.asp.
18. Centers for Disease Control and Prevention (CDC). Outbreaks Chronology: Ebola Virus Disease. http://www.cdc.gov/vhf/ebola/outbreaks/history/chronology.htmlhttp://www.cdc.gov/vhf/ebola/outbreaks/history/chronology.html.
19. CNN. Documents reveal al Qaeda's plans for seizing cruise ships, carnage in Europe. http://edition.cnn.com/2012/04/30/world/al-qaeda-documents-future/index.html.
20. Colebunders R., Borchert M. Ebola haemorrhagic fever-a review. J. Infect. 2000, 40(1):16-20.
21. Cronin A.K. Terrorist motivations for chemical and biological weapons use: placing the threat in context. Def. Secur. Anal. 2004, 20(4):313-320.
22. Dixon M.G., Schafer I.J. Ebola viral disease outbreak-West Africa, 2014. MMWR Morb. Mortal. Wkly. Rep. 2014, 63:548-551.
23. Dorminey B. Ebola as ISIS bio-weapon?. Forbes 2014.
24. Dvorin, T. (2014). Could ISIS target the West with Ebola? Arutz Sheva. Israel National News. http://www.israelnationalnews.com/News/News.aspx/186020#.VDvayfldWSo.
25. Feldmann H., Geisbert T.W. Ebola haemorrhagic fever. Lancet 2011, 377(9768):849-862.
26. Feldmann H., Klenk H.D. Filoviruses. Medical Microbiology 1996, University of Texas Medical Branch at Galveston, Galveston, TX, USA. 4th ed. S. Baron (Ed.).
27. Feldmann H., Jones S., Klenk H.D., Schnittler H.J. Ebola virus: from discovery to vaccine. Nat. Rev. Immunol. 2003, 3:677-685.
28. Furuta Y., Gowen B.B., Takahashi K., Shiraki K., Smee D.F., Barnard D.L. Favipiravir (T-705), a novel viral RNA polymerase inhibitor. Antivir. Res. 2013, 100(2):446-454.
29. Garrett L. Betrayal of Trust: The Collapse of Global Public Health 2001, Hyperion, New York, USA.
30. Gatherer D. The 2014 Ebola virus disease outbreak in West Africa. J. Gen. Virol. 2014, 95:1619-1624.
31. Greub G., Grobusch M.P. Bioterrorism: myth or reality?. Clin. Microbiol. Infect. 2014, 20:485-487.
32. Groseth A., Feldmann H., Strong J.E. The ecology of Ebola virus. Trends Microbiol. 2007, 15:408-416.
33. Guineenews. Medium des dernières nouvelles guinéennes par les guinéens. http://guineenews.org/2014/03/ebola-a-konakry-la-contamination-limitee-aux-membres-dune-seule-famille-et-a-ceux-qui-les-ont-approches/.
34. Henderson D.A. The looming threat of bioterrorism. Science 1999, 283(5406):1279-1282.
35. Hill-Cawthorne, G., Gilbert, G.L. (2014). Don't panic about Ebola's spread, here's what we can do instead. The conversation. http://theconversation.com/dont-panic-about-ebolas-spread-heres-what-we-can-do-instead-31559.
36. Isaacs D. Pandemic paranoia: a heretical view of Ebola and other infectious threats. J. Paediatr. Child Health 2015, 51(2):129-130.
37. Jaax N., Jahrling P., Geisbert T., Geisbert J., Steele K., McKee K., Nagley D., Johnson E., Jaax G., Peters C. Transmission of Ebola virus (Zaire strain) to uninfected control monkeys in a biocontainment laboratory. The Lancet 1995, 346(8991):1669-1671.
38. Jansen H.J., Breeveld F.J., Stijnis C., Grobusch M.P. Biological warfare, bioterrorism and biocrime. Clin. Microbiol. Infect. 2014, 20(6):488-496.
39. Johnson E., Jaax N., White J., Jahrling P. Lethal experimental infections of rhesus monkeys by aerosolized Ebola virus. Int. J. Exp. Pathol. 1995, 76(4):227-236.
40. Kagan E. Update on Ebola virus and its potential as a bioterrorism agent. Clin. Pulmon. Med. 2005, 12(2):76-83.
41. Katz R. Biological weapons: a national security problem that requires a public health response. OPR Working Paper Series 2004, Princeton University, Princeton, NJ, USA.
42. Lazarus A.A., Decker C.F. Plague. Respir. Care Clin. N. Am. 2004, 10:83-98.
43. Leitenberg M., Zilinskas R.A., Kuhn J.H. The Soviet Biological Weapons Program: A History 2012, Harvard University Press.
44. Leitenberg M. Biological weapons in the twentieth century: a review and analysis. Crit. Rev. Microbiol. 2001, 27:267-320.
45. Marzi A., Ebihara H., Callison J., Groseth A., Williams K.J., Geisbert T.W., Feldmann H. Vesicular stomatitis virus-based Ebola vaccines with improved cross-protective efficacy. J. Infect. Dis. 2011, 204(3):S1066-S1074.
46. Medecins Sans Frontieres (MSF). Ebola: Surviving Survival - Life after recovery. http://www.msf.org/article/ebola-surviving-survival-life-after-recovery.
47. Morris K. First pig-to-human transmission of Ebola-Reston virus. Lancet Infect. Dis. 2009, 9(3):148.
48. Morse S.S. Global infectious disease surveillance and health intelligence. Health Aff. 2007, 26(4):1069-1077.
49. National Institute of Allergy and Infectious Diseases (NIAID). NIAID/GSK Experimental Ebola Vaccine Appears Safe, Prompts Immune Response. Results from NIH Phase 1Clinical Trial Support Accelerated Development of Candidate Vaccine. http://www.niaid.nih.gov/news/newsreleases/2014/Pages/EbolaVaxResults.aspx.
50. Oestereich L., Lüdtke A., Wurr S., Rieger T., Muñoz-Fontela C., Günther S. Successful treatment of advanced Ebola virus infection with T-705 (favipiravir) in a small animal model. Antiviral research 2014, 105:17-21.
51. Olson K.B. Aum Shinrikyo: once and future threat?. Emerg. Infect. Dis. 1999, 5:513-516.
52. Piercy T.J., Smither S.J., Steward J.A., Eastaugh L., Lever M.S. The survival of filoviruses in liquids, on solid substrates and in a dynamic aerosol. J. Appl. Microbiol. 2010, 109:1531-1539.
53. Raevskiy A.E. Psychological aspects of the Aum Shinrikyo affair. Psychology in Russia. State Art 2014, 7(1):34-39.
54. Sagripanti J.L., Rom A.M., Holland L.E. Persistence in darkness of virulent alphaviruses, Ebola virus, and Lassa virus deposited on solid surfaces. Arch. Virol. 2010, 155(12):2035-2039.
55. Sanchez A., Ksiazek T.G., Rollin P.E., Peters C.J., Nichol S.T., Khan A.S., Mahy B.W. Reemergence of Ebola virus in Africa. Emerg. Infect. Dis. 1995, 1(3):96.
56. Teckman A.M. The bioterrorist threat of ebola in East Africa and implications for global health and security. Glob. Policy Essay 2013, 15.
57. The Lancet Ebola in west Africa: gaining community trust and confidence. Lancet 2014, 383(9933):1946.
58. U.S. National Institutes of Health. Partnership for Research on Ebola Vaccines in Liberia (PREVAIL) NCT02344407.
59. Üstun Ç., Özgurler O. Ebola: a significant threat as an infectious disease, and as potential bioterrorism agent. Turk. J. Med. Sci. 2005, 35(1):1-4.
60. Utgoff V.A. The biotechnology revolution and its potential military implications. Biological weapons: Weapons of the future. Biological Weapons: Weapons of the Future? 1993, Center for Strategic and International Studies, Washington DC, USA. Roberts, Browder (Eds.).
61. Van Aken J., Hammond E. Genetic engineering and biological weapons. EMBO Rep. 2003, 4(S1):S57-S60.
62. Wahl-Jensen V., Kurz S.K., Hazelton P.R., Schnittler H.J., Ströher U., Burton D.R., Feldmann H. Role of Ebola virus secreted glycoproteins and virus-like particles in activation of human macrophages. J. Virol. 2005, 79:2413-2419.
63. Weingartl H.M., Embury-Hyatt C., Nfon C., Leung A., Smith G., Kobinger G. Transmission of Ebola virus from pigs to non-human primates. Sci. Rep. 2012, 2:811.
64. World Healt Organization (WHO), 2015z. In vitro diagnostics and laboratory technology: Emergency Use Assessment and Listing (EUAL) Procedure for Ebola Virus Disease (IVDs). http://www.who.int/diagnostics_laboratory/procurement/150219_reebov_antigen_rapid_test_public_report.pdf.
65. World Health Organization (WHO) WHO influenza surveillance. Wkly. Epidemiol. Rec. 1996, 71:353-360.
66. World Health Organization (WHO). (2001). Outbreak of Ebola heamorrhagic fever, Uganda, August 2000-January 2001. http://who.int/csr/don/2001_02_09a/en.
67. World Healt Organization (WHO), 2015x. Essential medicines and health products. Ebola vaccines, therapies, and diagnostics. http://www.who.int/medicines/emp_ebola_q_as/en/.
68. World Health Organization (WHO), 2015y. Media Centre: Ebola Virus disease. Fact sheet N° 103. http://www.who.int/mediacentre/factsheets/fs103/en.
69. World Health Organization (WHO). Ebola Situation Report - 26 August 2015. http://apps.who.int/ebola/current-situation/ebola-situation-report-26-august-2015.
70. World Health Organization (WHO). Media Centre: WHO Director-General, west African presidents to launch intensified Ebola outbreak response plan. http://www.who.int/mediacentre/news/releases/2014/ebola-outbreak-response-plan/en/.
71. World Health Organization (WHO). Media Centre: Frequently asked questions on Ebola virus disease. http://who.int/csr/disease/ebola/faq-ebola/en/.
72. World Health Organizzation (WHO). Essential medicines and health products. WHO Ebola R&D Effort-vaccines, therapies, diagnostics. 30 January update. http://www.who.int/medicines/ebola-treatment/ebola_r_d_effort/en/.
73. World Health Organizzation (WHO). Essential medicines and health products. Categorization and prioritization of drugs for consideration for testing or use in patients infected with Ebola. http://who.int/medicines/ebola-treatment/cat_prioritization_drugs_testing/en/.